与酒精相关的肝病和与代谢功能障碍相关的脂肪性肝病:分子发病和治疗干预
Yupin Tan1, Yirui Hu1, Ye Yang1
1Division of Gastroenterology Union Hospital Tongji Medical College Huazhong University of Science and Technology Hubei China.
MedComm
|December 9, 2025
概括
与酒精相关的肝病 (ALD) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 具有共同的分子途径,如脂质代谢和免疫激活. 了解这些机制可以指导开发针对这两种疾病的向疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子病原体的产生.
- 翻译医学是一种翻译医学.
背景情况:
- 与酒精有关的肝病 (ALD) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 是全球慢性肝病的主要原因.
- 尽管取得了进展,但它们的致病机制尚未完全理解,有效的治疗方法仍然有限.
研究的目的:
- 综合分析ALD和MASLD的共享和分歧的分子致病机制.
- 系统地审查这些肝脏疾病的最新治疗干预策略.
主要方法:
- 关于ALD和MASLD分子病原学的当前文献的综述.
- 专注于共同的途径,包括脂质代谢,细胞死亡,衰老和肠道失调.
- 对分子事件的分析,如脂肪酸氧化,脂质生成,热,死和免疫信号的受损.
主要成果:
- 尽管有不同的原因,但ALD和MASLD共享关键的病理生理路径.
- 确定的共享分子事件包括不调节的脂质代谢,编程细胞死亡,细胞衰老和肠道失调.
- 肠道微生物群通过代谢物和与微生物相关的分子模式影响肝脏疾病.
结论:
- 对共享途径的机械洞察力可以为ALD和MASLD的精密治疗开发提供信息.
- 讨论了针对脂质代谢,细胞死亡,衰老,微生物群和免疫调节的治疗策略.
- 提出了一个机制框架,以指导未来的精准医学方法,用于这些普遍的肝脏疾病.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
196
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
196
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Chronic Pancreatitis I: Introduction
648
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
648
Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K


